Developer docs
API playgroundTry for free, no card

Search company profiles

GeneMatters

Full company profile

uuid0002fam

Namestring
GeneMatters
Websiteurl
gene-matters.com
Company typeenum
Private
Founded yearint
2016
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMinneapolis, United States
HQ citystring
Minneapolis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
genetic counseling services, clinical genetic consulting, telehealth genetic counseling, genomic health services, hereditary cancer counseling
Industry3 codes
1Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling)
CodeHLALAHAKPrimaryYes
2Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
CodeHLAAALADPrimaryNo
3Molecular & Genetic Testing (PCR/NGS/qPCR)
CodeHLAGADAFPrimaryNo
NAICS code2 codes
  • Educational Support Services61171
  • Individual and Family Services6241
SIC code2 codes
  • Services-Health Services8000
  • Services-Medical Laboratories8071
Product category
Genetic Counseling Services
Social media profiles1 record
Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

GeneMatters delivers genetic counseling services for hospitals, health networks, academic research centers, and genetic testing labs. The company supports client organizations by providing access to board-certified genetic counselors who help patients understand genetic test results and inherited disease risks. Services are positioned as an extension of client genetics programs rather than a direct consumer offering.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Genetic Counseling Services
Description

Delivery of genetic counseling services by GeneMatters' clinical team to hospitals, health networks, academic research centers, and genetic testing labs to support their patients and genetics programs.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1InformedDNA
TypeDirect peer
Description

Largest pure-play telehealth genetic counseling company in the US; acquired GeneMatters in 2021 and is the most direct competitor and now parent of the subject company. Both serve health systems and testing labs with licensed remote counselors.

2Genome Medical
TypeDirect peer
Description

Telehealth genetic counseling and clinical genomics services platform serving patients, providers, health systems, and testing labs. Directly comparable in delivery model and customer set to GeneMatters.

3Color Health
TypeBroad incumbent
Description

Genetic testing company that bundles genetic counseling into its population-health and hereditary cancer offerings. Competes for the same institutional buyers by offering an integrated testing-plus-counseling solution.

4Myriad Genetics
TypeBroad incumbent
Description

Established genetic testing lab that provides genetic counseling services alongside its hereditary cancer and reproductive health tests. Comparable as a vertically integrated competitor for health-system testing and counseling spend.

5Invitae
TypeBroad incumbent
Description

Large clinical genetic testing company offering counseling support for its germline and reproductive testing menu; competes for the same health-system and lab partnerships GeneMatters targets.

6Ambry Genetics
TypeBroad incumbent
Description

Clinical genetic testing lab providing hereditary cancer, reproductive, and rare disease testing with associated counseling services — comparable institutional buyer overlap and bundled-service risk.

7Natera
TypeBroad incumbent
Description

Genetic testing company with significant oncology and reproductive health franchises that offers counseling services to patients and providers; an adjacent competitor for institutional genetics budgets.

8GeneDx
TypeBroad incumbent
Description

Clinical genomics lab (now part of Sema4) with rare disease and hereditary testing plus counseling support; relevant institutional competitor in the same buyer pool.

9Concert Genetics
TypeEmerging player
Description

Genetics benefits management and data platform that interacts with health plans, providers, and labs around genetic testing utilization — adjacent to genetic counseling as part of the broader testing-services workflow.

10Progeny Genetics
TypeEmerging player
Description

Provider of pedigree and risk-assessment software used by genetics practices and counselors; comparable because it serves the same genetics professional workflow that GeneMatters supports with service delivery.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GeneMatters

Genetic Counseling Servicesgene-matters.com

GeneMatters firmographics

Firmographics
Name
GeneMatters
Website
https://gene-matters.com
Company type
Private
Founded year
2016
Headcount range
11–50 employees
Ownership category
akta.pro rank

GeneMatters industry classification

Industry
Product category
Genetic Counseling Services
NAICS
Educational Support Services (61171), Individual and Family Services (6241)
SIC
Services-Health Services (8000), Services-Medical Laboratories (8071)
akta.pro primary industry
Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK)
akta.pro secondary industries
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

  • Genetic counseling services
  • Clinical genetic consulting
  • Telehealth genetic counseling
  • Genomic health services
  • Hereditary cancer counseling

Where GeneMatters is headquartered

Location

Headquarters

HQ city
Minneapolis
HQ country
United States
HQ region
North America

Markets served

GeneMatters business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

GeneMatters product offering

Product offering

Core offering

GeneMatters delivers genetic counseling services for hospitals, health networks, academic research centers, and genetic testing labs. The company supports client organizations by providing access to board-certified genetic counselors who help patients understand genetic test results and inherited disease risks. Services are positioned as an extension of client genetics programs rather than a direct consumer offering.

Differentiator

Problem solved

Functional benefit

Products and services

  • Genetic Counseling Services Delivery of genetic counseling services by GeneMatters' clinical team to hospitals, health networks, academic research centers, and genetic testing labs to support their patients and genetics programs.

Companies that use GeneMatters

Customer profile

Ideal customer profiles3 records

GeneMatters technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

GeneMatters partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights3 records

GeneMatters competitors and assessment

Company assessment

Direct peers

  • InformedDNA: Largest pure-play telehealth genetic counseling company in the US; acquired GeneMatters in 2021 and is the most direct competitor and now parent of the subject company. Both serve health systems and testing labs with licensed remote counselors.
  • Genome Medical: Telehealth genetic counseling and clinical genomics services platform serving patients, providers, health systems, and testing labs. Directly comparable in delivery model and customer set to GeneMatters.

Broad incumbents

  • Color Health: Genetic testing company that bundles genetic counseling into its population-health and hereditary cancer offerings. Competes for the same institutional buyers by offering an integrated testing-plus-counseling solution.
  • Myriad Genetics: Established genetic testing lab that provides genetic counseling services alongside its hereditary cancer and reproductive health tests. Comparable as a vertically integrated competitor for health-system testing and counseling spend.
  • Invitae: Large clinical genetic testing company offering counseling support for its germline and reproductive testing menu; competes for the same health-system and lab partnerships GeneMatters targets.
  • Ambry Genetics: Clinical genetic testing lab providing hereditary cancer, reproductive, and rare disease testing with associated counseling services — comparable institutional buyer overlap and bundled-service risk.
  • Natera: Genetic testing company with significant oncology and reproductive health franchises that offers counseling services to patients and providers; an adjacent competitor for institutional genetics budgets.
  • GeneDx: Clinical genomics lab (now part of Sema4) with rare disease and hereditary testing plus counseling support; relevant institutional competitor in the same buyer pool.

Emerging players

  • Concert Genetics: Genetics benefits management and data platform that interacts with health plans, providers, and labs around genetic testing utilization — adjacent to genetic counseling as part of the broader testing-services workflow.
  • Progeny Genetics: Provider of pedigree and risk-assessment software used by genetics practices and counselors; comparable because it serves the same genetics professional workflow that GeneMatters supports with service delivery.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

GeneMatters social profiles

Digital presence

GeneMatters financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GeneMatters leadership team

Management profile

Number of profiles

GeneMatters funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GeneMatters M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GeneMatters

What does GeneMatters do?

GeneMatters delivers genetic counseling services for hospitals, health networks, academic research centers, and genetic testing labs. The company supports client organizations by providing access to board-certified genetic counselors who help patients understand genetic test results and inherited disease risks. Services are positioned as an extension of client genetics programs rather than a direct consumer offering.

When was GeneMatters founded?

GeneMatters was founded in 2016. It employs 11 to 50 people.

Where is GeneMatters based?

GeneMatters is headquartered in Minneapolis, United States, in the North America region.

Who are GeneMatters's main competitors?

Direct peers on record are InformedDNA and Genome Medical. Broad incumbents are Color Health, Myriad Genetics, Invitae, Ambry Genetics, Natera and GeneDx. Emerging players are Concert Genetics and Progeny Genetics.

Does GeneMatters have an API?

No public API is recorded for GeneMatters.

What industry is GeneMatters in?

GeneMatters's product category is Genetic Counseling Services. Its primary akta.pro industry code is HLALAHAK, Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling), with a secondary code of HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics). Its NAICS code is 61171 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogGenome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C FinancingGenome Medical announced it will acquire GeneMatters, a telehealth genetic counseling and software solutions company, while closing a $60 million Series C round led by Casdin Capital with participation from GV, Amgen Ventures and other investors. GeneMatters will operate as a wholly owned subsidiary, and proceeds will fund team expansion and technology development.WebrazziTele genetik danışmanlık hizmeti veren GeneMatters', Genome Medical tarafından satın alındıGenome Medical has acquired GeneMatters, a tele-genetics consulting platform, making it a wholly-owned subsidiary. Simultaneously, GeneMatters secured a $60 million investment led by Casdin Capital to expand its human resources and service offerings.PR NewswireInvenshure Announces GeneMatters acquisition as part of a $60M Series C financing of Genome MedicalGenome Medical has acquired GeneMatters, a Minneapolis-based telehealth genetic counseling provider, as part of its expansion strategy. This transaction is accompanied by a $60 million Series C financing round for Genome Medical, led by Casdin Capital with participation from new investors GV and Amgen Ventures.InvenshureInvenshure Announces GeneMatters acquisition as part of a $60M Series C financing of Genome Medical — InvenshureGenome Medical has acquired GeneMatters, a Minneapolis-based telehealth genetic counseling provider founded by Invenshure and Jill Davies. This acquisition is part of a $60 million Series C financing round for Genome Medical, which was led by Casdin Capital with participation from GV and Amgen Ventures. The strategic combination aims to expand Genome Medical's clinical capacity and expertise in delivering genomic care services.HealthEconomics.comGeneMatters and Concert Genetics Partner to Offer Personalized Genetics ServicesGeneMatters and Concert Genetics announced a partnership to provide personalized genetics services in clinical settings. The collaboration combines GeneMatters' tech-enabled care delivery with Concert's test order management platform to address the growing demand for remote medical services. This strategic alliance aims to help healthcare providers deliver efficient, end-to-end genetics-informed care.PR NewswireGeneMatters and Concert Genetics Partner to Scale Tech-Enabled Clinical Genetics ServicesGeneMatters and Concert Genetics announced a partnership to help healthcare systems meet rising patient demand for high-quality clinical genetics services by combining Concert's SaaS platform for genetic test ordering and resulting with GeneMatters' virtual genetic counselors, care delivery software, and patient engagement tools. The collaboration addresses rapid growth in the genetic counseling field, which doubled in the last decade and is projected to grow twice as fast as other healthcare occupations through 2029, alongside telemedicine visits that increased over 2,000% in early 2020. The combined solutions will be available to both companies' respective health system customers immediately.PR NewswireEpisona Enters Consumer Market with Epigenetics Test for Male InfertilityEpisona Inc. announced the launch of its Seed test for male infertility to the consumer market, allowing patients to order the epigenetics-based diagnostic kit online for at-home use. The service includes semen sample analysis at a CLIA-certified lab and provides detailed reports alongside genetic counseling services from Gene Matters to help patients make informed decisions about fertility treatments.